CATX

Perspective Therapeutics, Inc. CATX

NYSESmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$-26.79M

Quarter to Jun 30

Free cash flow

$-34.84M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$296.71M total
BlackRock, Inc.
$32.38M+77.5%
TCG Crossover Management, LLC
$26.99M0.0%
Commodore Capital LP
$21.61M0.0%
Avidity Partners Management LP
$21.48M+4.1%
STATE STREET CORP
$20.64M+93.2%
MILLENNIUM MANAGEMENT LLC
$16.75M+21.4%
VANGUARD CAPITAL MANAGEMENT LLC
$15.13M+1.3%
Affinity Asset Advisors, LLC
$14.37M+33.2%
CITADEL ADVISORS LLC
$12.98M+6.7%
Spruce Street Capital LP
$12.60M+40.6%
BALYASNY ASSET MANAGEMENT L.P.
$11.32M+10.9%
GEODE CAPITAL MANAGEMENT, LLC
$8.39M+39.1%
Nantahala Capital Management, LLC
$7.93MNew
MORGAN STANLEY
$6.52M-35.9%
GOLDMAN SACHS GROUP INC
$5.91M+39.6%
Nicholson Wealth Management Group, LLC
$5.52M+0.1%
TWO SIGMA INVESTMENTS, LP
$5.31M+55.1%
ADAR1 Capital Management, LLC
$4.13M+61.5%
VANGUARD PORTFOLIO MANAGEMENT LLC
$3.71M+44.6%
DIMENSIONAL FUND ADVISORS LP
$3.66M+138.6%
Yu Fan
$3.60M0.0%
Hills Bank & Trust Co
$2.97M0.0%
NORTHERN TRUST CORP
$2.70M+49.7%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$2.64M+16.9%
Ally Bridge Group (NY) LLC
$2.54M-19.7%
See all 130 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q4 2026
EDGAR

EPS (Diluted)

Q4 2026
EDGAR

ROIC

Q4 2026
EDGAR

Free Cash Flow

Q4 2026
EDGAR

Debt/Equity

Q4 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/CATX

Earnings Per Share

13fpro.ai/company/CATX

Loading ratio trend…

CATX insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Perspective Therapeutics, Inc. (CATX): stock profile, AI score and financials

Perspective Therapeutics, Inc. (CATX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. CATX is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q4 2026), Perspective Therapeutics, Inc. reports net income of $-26.8M, free cash flow of $-34.8M. CATX trades on the NYSE exchange and files with the SEC under CIK 728387. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CATX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Perspective Therapeutics, Inc. directly from SEC EDGAR.

SEC EDGAR: CIK 728387 →